¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"specific reading disorder"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • cumulative trauma disorder
    ´©Àû¿Ü»óÀå¾Ö
  • cyclothymic disorder
    ¼øÈ¯±âºÐÀå¾Ö
  • central auditory processing disorder
    ÁßÃßû°¢Ã³¸®Àå¾Ö
  • childhood anxiety disorder
    ¼Ò¾ÆºÒ¾ÈÀå¾Ö
  • chromosomal disorder
    ¿°»öüÀå¾Ö
  • chronic myeloproliferative disorder
    ¸¸¼º°ñ¼öÁõ½ÄÁúȯ
  • dysthymic disorder
    ±âºÐÀúÇÏÀå¾Ö
  • delusional disorder
    ¸Á»óÀå¾Ö
  • demyelinating disorder
    ¸»ÀÌÁýÅ»¶ôÁúȯ, Å»¼öÃÊÁúȯ
  • dependent personality disorder
    ÀÇÁ¸ÀΰÝÀå¾Ö
  • depersonalization disorder
    ÀÌÀÎ(ìÆìÑ)Àå¾Ö
  • depressive disorder
    ¿ì¿ïÀå¾Ö
  • developmental disorder
    ¹ß´ÞÀå¾Ö
  • developmental receptive language disorder
    ¹ß´Þ¼ö¿ë¾ð¾îÀå¾Ö
  • disorder
    1. Àå¾Ö 2. º´ 3. Áúȯ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • compulsive personality disorder
    °­¹ÚÀΰÝÀå¾Ö
  • conduct disorder
    Çà½ÇÀå¾Ö, Çà½Çº´
  • conversion disorder
    ÀüȯÀå¾Ö, Àüȯº´
  • conversion voice disorder
    ÀüȯÀ½¼ºÀå¾Ö
  • coordination disorder
    ÇùÀÀÀå¾Ö
  • cutaneous disorder
    ÇǺÎÁúȯ
  • cyclothymic disorder
    ¼øÈ¯¼º±âºÐÀå¾Ö
  • disorder
    Àå¾Ö, Áúȯ
  • delusional disorder
    ¸Á»óÀå¾Ö
  • demyelinating disorder
    ¸»ÀÌÁýÅ»¶ôÁúȯ
  • dependent personality disorder
    ÀÇÁ¸ÀΰÝÀå¾Ö
  • depersonalization disorder
    ÀÌÀÎÀå¾Ö
  • depressive disorder
    ¿ì¿ïÀå¾Ö
  • developmental disorder
    ¹ß´ÞÀå¾Ö
  • developmental receptive language disorder
    ¹ß´Þ¼ö¿ë¾ð¾îÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • personality disorder, passive
    ¼öµ¿¼º(áôÔÑàõ) ÀΰÝÀå¾Ö
  • personality disorder, passive-aggressive
    ¼öµ¿°ø°Ý¼º ÀΰÝÀå¾Ö
  • personality disorder, psychopathic
    Á¤½Åº´Áú(ïñãêÜ»òõ)¼º ÀΰÝÀå¾Ö
  • personality disorder, schizoid
    ºÐ¿­¼º(ÝÂæñàõ) ÀΰÝÀå¾Ö
  • personality disorder, schizotypal
    ºÐ¿­Çü ÀΰÝÀå¾Ö
  • personality disorder, self- defeating
    ÀÚ±âÆÐ¹è¼º(í»Ðùø¨ÛÅàõ) ÀΰÝÀå¾Ö
  • personality disorder, sociopathic
    »çȸº´Áú¼º(ÞäüåÜ»òõàõ) ÀΰÝÀå¾Ö
  • pervasive developmental disorder
    Àü¹ÝÀû ¹ß´ÞÀå¾Ö(îïÚõîÜÛ¡Ó¹î¡äô)
  • phencyclidine use disorder
    Ææ½ÎÀÌŬ¸®µò »ç¿ëÀå¾Ö(º´)
  • phobic anxiety disorder
    °øÆ÷ºÒ¾ÈÀå¾Ö, ~º´
  • phobic disorder
    °øÆ÷Àå¾Ö,°øÆ÷º´
  • phonation disorder
    ¹ß¼ºÀå¾Ö
  • phonological disorder
    À½¼ºÇÐÀû Àå¾Ö, ~ º´
  • physiological disorder
    »ý¸® Àå¾Ö
  • platelet disorder
    Ç÷¼ÒÆÇÁúȯ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • specific growth rate
    ƯÁ¤Áõ½ÄÀ²
  • specific heat
    ºñ¿­(Ýïæð).
  • specific humidity
    ºñ½Àµµ.
  • specific inflammation
    ƯÀ̼º¿°(¡­àõæú)
  • specific inhibitor
    ƯÀÌÀû ¾ïÁ¦Á¦.
  • specific ionization
    ƯÀÌÀÌ¿ÂÈ­.
  • specific marriage rate
    ƯÁ¤°áÈ¥À²(Ì¬Ëø Ë­Ì´Ëô).
  • specific morbidity rate
    ƯÁ¤ÀÌȯÀ²(Ì¬Ëø ËöÌ·Ëô).
  • specific mortality rate
    ƯÁ¤»ç¸Á·ü(Ì¬Ëø Ë×ËÎËô).
  • specific muscle force
    ºñ±Ù·Â(ÝïÐÉæ³).
  • specific muscle force
    ºñ±Ù ·Â(ÝïÐÉæ³).
  • specific nerve energy
    Ư¼ö½Å°æ(÷åâ¨ãêÌè) ¿¡³ÊÁö.
  • specific nuclei
    Ư¼öÇÙ.
  • specific pathogen free animal
    ƯÁ¤¹«±Õµ¿¹°(÷åïÒÙíжÔÑÚª).
  • specific pathogen free animal
    ƯÁ¤¹«±Õµ¿¹°(÷åïÒÙíжÔÑÚª).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
ADD/HA attention deficit disorder/hyperactivity
ADHD attention deficit-hyperactivity disorder
AIMD abnormal involuntary movement disorder
BGMR basal ganglion disorder with mental retardation
BP II bipolar II disorder
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
CAPD Central Auditory Processing Disorder
CD Conduct Disorder
DD Delusional disorder
DCD Developmental Co-ordination Disorder
DLD Developmental language disorder
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • late luteal phase dysphoric disorder
    ¸»±â Ȳü±â ºÒÄè Àå¾Ö
  • major depressive disorder
    ÁÖ¿ä ¿ì¿ïÁõ
  • masticatory muscle pain disorder
    ÀúÀÛ±Ù µ¿Åë Àå¾Ö
  • menopausal disorder
    °»³â±â Àå¾Ö
    °»³â±â¿¡ »ý±â´Â ÀÚÀ²½Å°æ ½ÇÁ¶Áõ. ³­¼ÒÀÇ ³»ºÐºñ ±â´ÉÀÇ °¨Å𳪠ÆóÀýÀÌ ÁÖµÈ ¿øÀÎÀ̸ç, ¶ÇÇÑ °¢Á¾ÀÇ ³»ºÐºñ¼±, ƯÈ÷ ³úÇϼöü Àü¿±, °©»ó¼±, ºÎ½Å ¶Ç´Â ÃéÀå µîÀÇ ±â´ÉÀå¾Ö·Î ±×µé »óÈ£°£ÀÇ ÆòÇü ½ÇÁ¶¸¦ °¡Á®¿À°í, ³¡³»´Â ³»ºÐºñ Àå±â¸¦ Áö¹èÇÏ´Â ÀÚÀ²½Å°æ °èÅë¿¡ ¿µÇâÀ» ³¢ÃÄ ±³°¨½Å°æ ¶Ç´Â ºÎ±³°¨½Å°æ¿¡ ±äÀåÀ» ÃÊ·¡Çϱ⠶§¹®À̶ó°í ¿©°ÜÁö°í ÀÖ´Ù. Áõ¼¼¿¡´Â ±¹ºÎÀû Áõ¼¼¿Í Àü½Å Áõ¼¼°¡ ÀÖ´Ù. ±¹ºÎÀûÀÎ Áõ¼¼·Î´Â ³»¿Ü ¼º±âÀÇ À§ÃàÀÌ ÁÖµÈ Áõ»óÀÌ´Ù. ¿Ü¼º±âÀÎ ´ë, ¼ÒÀ½¼øÀº Áö¹æÀÇ ¼Ò½Ç·Î À§ÃàµÇ°í, À½¸ð´Â ¹«»öÀÌ µÈ´Ù. ³»¼º±â¿¡¼­´Â Áú º®ÀÌ ÆòÆòÇØÁö°í Áú °­Àº Á¼¾ÆÁö´Âµ¥, ¶§·Î´Â Áú¿° ¶§¹®¿¡ Áú °­ÀÌ À¯ÂøµÈ´Ù. ÀÚ±ÃÀº ±Ù¼¶À¯ÀÇ À§ÃàÀ¸·Î ÀüüÀûÀ¸·Î Âɱ׶óµé¸ç, °æ°ü ¹× ³» Àڱà ±¸´Â ¸Å¿ì Á¼¾ÆÁ®¼­ ¶§·Î´Â Æó¼âµÇ¾î À¯¼öÁ¾ ¶Ç´Â À¯³óÁ¾ÀÌ »ý±æ ¶§µµ ÀÖ´Ù. ³­¼Ò´Â ÀÛ¾ÆÁö°í ±â´Éµµ °¨ÅðÇÏ¿© ƯÀ¯ÀÇ ³­¼Ò ÁÖ±âÀÇ ºÒ±ÔĢȭ¿¡ µû¶ó ¿ù°æ ºÒ¼øÀ» ÀÏÀ¸Å°¸ç ¿ÏÀü Æó°æ¿¡ À̸¥´Ù. ³­°ü, Àڱà Àδë, º¹¸· µîµµ À§ÃàÇÑ´Ù. Á¦2Â÷ ¼ºÂ¡À¸·Î À¯¹æ°ú Àü½Å¿¡ °ÉÃÄ ÇÇÇÏ Áö¹æ Á¶Á÷ÀÇ ¼Ò½ÇÀÌ ÀϾ ¿©¼º´Ù¿î ¸ö¸Å¸¦ ÀÒ°Ô µÇ°í, ½ÉÁö¾î´Â ÀÔ°¡¿¡ ¼ö¿°ÀÌ ³ª´Â µî ³²¼ºÀûÀ¸·Î º¯¸ðÇÏ´Â °æ¿ìµµ ÀÖ´Ù. Àü½ÅÀÇ Áõ¼¼·Î´Â Ç÷°ü ¿îµ¿ ½Å°æ Àå¾Ö¿Í ÀÚÀ²½Å°æÁõÀÎ ¿­°¨, ³ÃÁõ, ÈïºÐ°¨, ½É°è Ç×Áø, ºÎÁ¤¸Æ, ºÎÁ¾ µîÀÌ ÀÖ´Ù. Á¤½Å ½Å°æ Àå¾Ö·Î´Â µÎÅë, µÎÁß°¨, Çö±âÁõ, ºÒ¸éÁõ, À̸íÁõ, ¿ì¿ïÁõ
  • metabolism disorder
    ´ë»ç Àå¾Ö
  • monopolar disorder
    ´Ü±Ø¼º Àå¾Ö
  • mood disorder
    ±âºÐ Àå¾Ö
  • motor output disorder
    ¿îµ¿¼º Ãâ·Â Àå¾Ö
  • motor skills disorder
    ¿îµ¿ ´É·Â Àå¾Ö
  • multisystem disorder
    ´Ù¹ßÀû Àü½Å ÀÌ»ó
  • muscle disorder
    ±ÙÀ° Àå¾Ö, ±Ù Àå¾Ö
  • muscle origin disorder
    ±ÙÀ°¼º Àå¾Ö
  • muscular disorder
    ±ÙÀ° Àå¾Ö
  • musculoskeletal pain disorder
    ±Ù °ñ°Ý¼º µ¿Åë Àå¾Ö
  • myalgic disorder
    ±ÙÀ°Åë Àå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
IgA-specific serine endopeptidase <enzyme> Extracellular microbial enzymes whose only substrate is human IgA of the iga1 subclass; cleave the immunoglobulin at a specific internal prolyl-threonyl peptide bond in the heavy chain to yield intact faba and fca fragments; consider also EC 3.4.24.13
Registry number: EC 3.4.21.72
Synonym: immunoglobulin a(1) protease, iga1 protease, immunoglobulin a1 protease, IgA protease
(26 Jun 1999)
organ-specific Denoting or pertaining to a serum produced by the injection of the cells of a certain organ or tissue that, when injected into another animal, destroys the cells of the corresponding organ.
(05 Mar 2000)
organ-specific antigen A heterogenetic antigen with organ specificity; e.g., in addition to species-specific antigen, kidney of one species contains antigen that is identical to that in kidney of other species.
Synonym: tissue-specific antigen.
(05 Mar 2000)
tail-specific protease <enzyme> Selectively degrades proteins with nonpolar c termini
Registry number: EC 3.4.99.-
Synonym: tsp protease, prc protein, prc gene product
(26 Jun 1999)
tissue-specific antigen A heterogenetic antigen with organ specificity; e.g., in addition to species-specific antigen, kidney of one species contains antigen that is identical to that in kidney of other species.
Synonym: tissue-specific antigen.
(05 Mar 2000)
tumour specific antigen <immunology, oncology> Antigen on tumour cells detected by cell-mediated immunity. For virus transformed cells TSTA (unlike T antigen) is found to differ for different individual tumours induced by the same virus. May consist of fragments of T antigens exposed at the cell surface.
(18 Nov 1997)
tumour-specific transplantation antigens Surface antigen's of DNA tumour virus-transformed cells, which elicit an immune rejection of the virus-free cells when transplanted into an animal that has been immunised against the specific cell-transforming virus.
(05 Mar 2000)
uridine-specific acid nuclease <enzyme> Chicken liver enzyme hydrolyzes poly(u) and e. Coli RNA
Registry number: EC 3.1.-
(26 Jun 1999)
fluoroacetate-specific dehalogenase <enzyme> Acts on fluoroacetamide at 0.1 the rate for fluoroacetate
Registry number: EC 3.8.1.-
Synonym: fluoroacetate-specific defluorinase, fac dehalogenase
(26 Jun 1999)
law of specific nerve energies Each type of sensory nerve ending, however stimulated (electrically, mechanically, etc.), gives rise to its own specific sensation; moreover, each type of sensation depends not upon any special character of the different nerves but upon the part of the brain in which their fibres terminate.
Synonym: law of specific nerve energies.
(05 Mar 2000)
lymphocyte specific protein tyrosine kinase p56(lck) <enzyme> This enzyme is a lymphoid specific src family tyrosine kinase that is critical for T-cell development and activation. Lck is associated with the cytoplasmic domains of CD4, CD8 and the beta-chain of the il-2 receptor, and is thought to be involved in the earliest steps of tcr-mediated T-cell activation.
Registry number: EC 2.7.11.-
(12 Dec 1998)
affective personality disorder A disturbance of feelings or mood expressed as a milder form of depression and related emotional features that colour the whole psychic life and for which psychosocial stressors are believed to play the major role.
(05 Mar 2000)
alcohol amnestic disorder <psychiatry> A mental disorder with brain damage characterised by amnesia, compensatory confabulation, disturbance of attention, and peripheral neuritis. It is usually associated with alcoholism and dietary deficiencies.
(12 Dec 1998)
antisocial personality disorder <psychiatry> An individual who engages in deviant behaviour with lack of remorse.
(13 Jan 1998)
asthenic personality disorder A personality type characterised by low energy level, easy fatigability, incapacity for enjoyment, lack of enthusiasm, and oversensitivity to physical and emotional stress. When appearing in marked form it becomes a psychological disorder (asthenic personality disorder), also called dependent personality.
Synonym: asthenic personality disorder, dependent personality disorder.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á